Tandem Diabetes Care TNDM Finished goods
Finished goods at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:InventoryFinishedGoods.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's finished goods.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's finished goods?
- Tandem Diabetes Care (TNDM) reported finished goods of $65.92M in Q1 2026.
- How has Tandem Diabetes Care's finished goods changed year-over-year?
- Tandem Diabetes Care's finished goods decreased by 11.5% year-over-year, from $74.49M to $65.92M.
- What is the long-term trend for Tandem Diabetes Care's finished goods?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's finished goods has grown at a 33.6% compound annual growth rate (CAGR), from $17.18M to $73.19M.
- What does finished goods mean?
- Completed products ready for sale, valued at the lower of cost or net realizable value.